Detalhe da pesquisa
1.
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer.
Nature;
615(7950): 168-174, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36813961
2.
Virus-induced senescence is a driver and therapeutic target in COVID-19.
Nature;
599(7884): 283-289, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34517409
3.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol;
80(3): 431-442, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37972660
4.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Blood;
140(26): 2773-2787, 2022 12 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36126318
5.
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.
Haematologica;
2024 04 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38572549
6.
Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma.
Clin Chem;
69(3): 295-307, 2023 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36644936
7.
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.
Hepatology;
76(4): 1000-1012, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35313048
8.
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma.
Liver Int;
42(11): 2538-2547, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35986902
9.
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection;
2024 Feb 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38388854
10.
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection;
2024 May 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38771466
11.
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.
Am J Hematol;
97(8): E312-E317, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35702878
12.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma;
65(2): 199-208, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37966980
13.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine;
71: 102553, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38533127
14.
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma.
Hepatol Int;
17(4): 904-914, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37005953
15.
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.
Hepatol Commun;
7(11)2023 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37889520
16.
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Ther Adv Hematol;
14: 20406207231154706, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36923264
17.
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Front Immunol;
14: 1125030, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36911708
18.
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.
J Hematol Oncol;
16(1): 32, 2023 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37005697
19.
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.
Blood Adv;
7(11): 2645-2655, 2023 06 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37058479
20.
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry.
EClinicalMedicine;
58: 101939, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37041967